ARTICLE | Company News
Matritech other research news
January 30, 1995 8:00 AM UTC
NMPS received an $88,000 Phase I SBIR from the National Cancer Institute to clone the gene that expresses PC-1. NMPS (Cambridge, Mass.) has obtained exclusive rights from Johns Hopkins for commercial,...